| Business Summary | | Magna-Lab,
Inc.
is
principally
engaged
in
the
development
of
disposable
diagnostic
imaging
devices
for
use
in
enhancing
the
effectiveness
of
MRI
for
the
detection
and
diagnoses
of
CAD
and
the
business
development
activities
necessary
to
bring
such
products
to
the
marketplace.
These
devices
are
intended
to
significantly
enhance
the
diagnostic
image
created
by
MRI
to
make
MRI
essential
in
the
diagnosis
and
as
a
guide
in
the
treatment
of
CAD.
The
Company
believes
that
MRI,
because
of
its
particular
effectiveness
with
soft
tissue,
can
play
a
critical
role
in
diagnosis
for
heart
disease. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Magna-Lab,
Inc.
is
principally
engaged
in
the
development
of
disposable
diagnostic
imaging
devices
for
use
in
enhancing
the
effectiveness
of
MRI
for
detection
and
diagnoses
of
CAD.
For
three
months
ended
5/31/01,
the
Company
reported
no
revenues.
Net
loss
totaled
$847
thousand,
up
from
$334
thousand.
Results
reflect
the
activities
related
to
recently
received
clearance
from
the
FDA
allowing
the
Company
to
market
its
Cardiac
View
Probe
and
Cardiac
View
Surface
Coil. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2001
Compensation | | Pay | Exer | |
| Daniel Mulvena, 53 Chairman | $185K | -- | John Geisel, 56 CEO,
Director | 33K | -- | Lawrence Minkoff, Ph.D., 52 Pres,
CSO | 195K | -- | J. Feldman, 57 VP,
Director | 256K | -- | Allen Perres, 49 VP | 184K | $1.3M | Dollar amounts are as of 28-Feb-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|